204 related articles for article (PubMed ID: 32376268)
1. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
Li XT; Li YS; Shi ZY; Guo XL
Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
[TBL] [Abstract][Full Text] [Related]
2. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
3. TRAP1 Chaperones the Metabolic Switch in Cancer.
Wengert LA; Backe SJ; Bourboulia D; Mollapour M; Woodford MR
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740911
[TBL] [Abstract][Full Text] [Related]
4. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
[TBL] [Abstract][Full Text] [Related]
5. Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.
Kang S; Kang BH
J Med Chem; 2022 Dec; 65(24):16155-16172. PubMed ID: 36507721
[TBL] [Abstract][Full Text] [Related]
6. The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy.
Xie S; Wang X; Gan S; Tang X; Kang X; Zhu S
Front Oncol; 2020; 10():585047. PubMed ID: 33575209
[TBL] [Abstract][Full Text] [Related]
7. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
[No Abstract] [Full Text] [Related]
8. HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.
Laquatra C; Sanchez-Martin C; Dinarello A; Cannino G; Minervini G; Moroni E; Schiavone M; Tosatto S; Argenton F; Colombo G; Bernardi P; Masgras I; Rasola A
Cell Death Dis; 2021 May; 12(5):434. PubMed ID: 33934112
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening.
Xiang F; Huang YS; Shi XH; Zhang Q
FEBS J; 2010 Apr; 277(8):1929-38. PubMed ID: 20236315
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
Landriscina M; Amoroso MR; Piscazzi A; Esposito F
Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
[TBL] [Abstract][Full Text] [Related]
11. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
[TBL] [Abstract][Full Text] [Related]
12. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
13. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives.
Serapian SA; Sanchez-Martín C; Moroni E; Rasola A; Colombo G
Trends Pharmacol Sci; 2021 Jul; 42(7):566-576. PubMed ID: 33992469
[TBL] [Abstract][Full Text] [Related]
14. Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site.
Yoon NG; Lee H; Kim SY; Hu S; Kim D; Yang S; Hong KB; Lee JH; Kang S; Kim BG; Myung K; Lee C; Kang BH
J Am Chem Soc; 2021 Dec; 143(47):19684-19696. PubMed ID: 34758612
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
Siegelin MD
Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism.
Ramkumar B; Dharaskar SP; Mounika G; Paithankar K; Sreedhar AS
Mitochondrion; 2020 Jan; 50():42-50. PubMed ID: 31669620
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
[TBL] [Abstract][Full Text] [Related]
20. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis.
Yoshida S; Tsutsumi S; Muhlebach G; Sourbier C; Lee MJ; Lee S; Vartholomaiou E; Tatokoro M; Beebe K; Miyajima N; Mohney RP; Chen Y; Hasumi H; Xu W; Fukushima H; Nakamura K; Koga F; Kihara K; Trepel J; Picard D; Neckers L
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):E1604-12. PubMed ID: 23564345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
